Postinflammatory hyperpigmentation associated with treatment of solar lentigines using a Q-Switched 532-nm Nd

YAG laser: a multicenter survey

Hyun Ji Kang, Jung Im Na, Jong Hee Lee, MiRyung Roh, Joo Yeon Ko, Sung Eun Chang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: To characterize the risk factors of Korean patients for postinflammatory hyperpigmentation (PIH) during treatment of solar lentigines using a Q-switched 532-nm Nd: YAG (QS 532 NY) laser. Materials and Methods: The present retrospective multicenter study was conducted at the dermatology clinics of five tertiary hospitals in Korea. Between October 2007 and January 2013, 516 patients were enrolled and reviewed for clinical features and factors associated with PIH. Results: The overall incidence of PIH was 20.3%. We demonstrated that patients with erythematous lentigines presented with PIH more frequently compared with those without erythematous lentigines. Among several coexisting conditions, facial diffuse dyschromia was significantly associated with PIH. Furthermore, PIH occurred more frequently in patients with invisible pores and velvety skin. However, age, sex, Fitzpatrick skin’s phototype and season of treatment showed little association with PIH. Conclusions: When a QS 532 NY laser is used to treat individuals with erythematous lentigines, invisible pores and velvety skin, and facial diffuse dyschromia, clinicians should be cautious and consider preventive measures.

Original languageEnglish
Pages (from-to)447-451
Number of pages5
JournalJournal of Dermatological Treatment
Volume28
Issue number5
DOIs
Publication statusPublished - 2017 Jul 4

Fingerprint

Lentigo
Hyperpigmentation
Solid-State Lasers
Skin
Therapeutics
Korea
Dermatology
Surveys and Questionnaires
Tertiary Care Centers
Multicenter Studies
Retrospective Studies
Incidence

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

@article{170964465ec2437fa262ebfc43e8920d,
title = "Postinflammatory hyperpigmentation associated with treatment of solar lentigines using a Q-Switched 532-nm Nd: YAG laser: a multicenter survey",
abstract = "Purpose: To characterize the risk factors of Korean patients for postinflammatory hyperpigmentation (PIH) during treatment of solar lentigines using a Q-switched 532-nm Nd: YAG (QS 532 NY) laser. Materials and Methods: The present retrospective multicenter study was conducted at the dermatology clinics of five tertiary hospitals in Korea. Between October 2007 and January 2013, 516 patients were enrolled and reviewed for clinical features and factors associated with PIH. Results: The overall incidence of PIH was 20.3{\%}. We demonstrated that patients with erythematous lentigines presented with PIH more frequently compared with those without erythematous lentigines. Among several coexisting conditions, facial diffuse dyschromia was significantly associated with PIH. Furthermore, PIH occurred more frequently in patients with invisible pores and velvety skin. However, age, sex, Fitzpatrick skin’s phototype and season of treatment showed little association with PIH. Conclusions: When a QS 532 NY laser is used to treat individuals with erythematous lentigines, invisible pores and velvety skin, and facial diffuse dyschromia, clinicians should be cautious and consider preventive measures.",
author = "Kang, {Hyun Ji} and Na, {Jung Im} and Lee, {Jong Hee} and MiRyung Roh and Ko, {Joo Yeon} and Chang, {Sung Eun}",
year = "2017",
month = "7",
day = "4",
doi = "10.1080/09546634.2016.1254330",
language = "English",
volume = "28",
pages = "447--451",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "5",

}

Postinflammatory hyperpigmentation associated with treatment of solar lentigines using a Q-Switched 532-nm Nd : YAG laser: a multicenter survey. / Kang, Hyun Ji; Na, Jung Im; Lee, Jong Hee; Roh, MiRyung; Ko, Joo Yeon; Chang, Sung Eun.

In: Journal of Dermatological Treatment, Vol. 28, No. 5, 04.07.2017, p. 447-451.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Postinflammatory hyperpigmentation associated with treatment of solar lentigines using a Q-Switched 532-nm Nd

T2 - YAG laser: a multicenter survey

AU - Kang, Hyun Ji

AU - Na, Jung Im

AU - Lee, Jong Hee

AU - Roh, MiRyung

AU - Ko, Joo Yeon

AU - Chang, Sung Eun

PY - 2017/7/4

Y1 - 2017/7/4

N2 - Purpose: To characterize the risk factors of Korean patients for postinflammatory hyperpigmentation (PIH) during treatment of solar lentigines using a Q-switched 532-nm Nd: YAG (QS 532 NY) laser. Materials and Methods: The present retrospective multicenter study was conducted at the dermatology clinics of five tertiary hospitals in Korea. Between October 2007 and January 2013, 516 patients were enrolled and reviewed for clinical features and factors associated with PIH. Results: The overall incidence of PIH was 20.3%. We demonstrated that patients with erythematous lentigines presented with PIH more frequently compared with those without erythematous lentigines. Among several coexisting conditions, facial diffuse dyschromia was significantly associated with PIH. Furthermore, PIH occurred more frequently in patients with invisible pores and velvety skin. However, age, sex, Fitzpatrick skin’s phototype and season of treatment showed little association with PIH. Conclusions: When a QS 532 NY laser is used to treat individuals with erythematous lentigines, invisible pores and velvety skin, and facial diffuse dyschromia, clinicians should be cautious and consider preventive measures.

AB - Purpose: To characterize the risk factors of Korean patients for postinflammatory hyperpigmentation (PIH) during treatment of solar lentigines using a Q-switched 532-nm Nd: YAG (QS 532 NY) laser. Materials and Methods: The present retrospective multicenter study was conducted at the dermatology clinics of five tertiary hospitals in Korea. Between October 2007 and January 2013, 516 patients were enrolled and reviewed for clinical features and factors associated with PIH. Results: The overall incidence of PIH was 20.3%. We demonstrated that patients with erythematous lentigines presented with PIH more frequently compared with those without erythematous lentigines. Among several coexisting conditions, facial diffuse dyschromia was significantly associated with PIH. Furthermore, PIH occurred more frequently in patients with invisible pores and velvety skin. However, age, sex, Fitzpatrick skin’s phototype and season of treatment showed little association with PIH. Conclusions: When a QS 532 NY laser is used to treat individuals with erythematous lentigines, invisible pores and velvety skin, and facial diffuse dyschromia, clinicians should be cautious and consider preventive measures.

UR - http://www.scopus.com/inward/record.url?scp=84995495552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995495552&partnerID=8YFLogxK

U2 - 10.1080/09546634.2016.1254330

DO - 10.1080/09546634.2016.1254330

M3 - Article

VL - 28

SP - 447

EP - 451

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 5

ER -